Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 13, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • immunization

Tag: immunization

  • Biotechnopedia
  • DNA-Tales

ADE: Antibody Assisted Entry of Viruses

DNA tales August 24, 2021August 24, 2021 1

Aayushi Gaur, University Institute of Engineering and Technology, Kurukshetra University Antiviral antibodies, in general, are considered antiviral because they play an important role in the control of virus infections in a variety of ways. But the presence of these antibodies might be advantageous to the virus in some cases. Antibody-dependent enhancement (ADE) of viral infections […]

Read More
  • BiotechToday
  • World

Can Lupus & rheumatoid arthritis patients safely get Covid jabs?

BioTech Today August 6, 2021August 5, 2021

Soumya Shraddhya Paul, Amity University, Noida Rheumatoid arthritis patients may be afraid that the COVID-19 vaccination will have negative side effects, aggravating their disease. Some people have even said that they do not believe it is safe for them to get the vaccine. That, however, is not the case. According to specialists, the chances of […]

Read More
  • BiotechToday
  • World

Cervical cancer screening task: ASCCP

bioxone August 2, 2021August 1, 2021 1

Ananya Ghosal, MAKAUT(WB) Guidelines of ASCCP The American cancer society (ASC) released the screening guideline for cervical cancer. The guideline initiates a shift in practice to Human papilloma Virus (HPV) screening at the age of 25-65 years in people with the cervix. The American Society for colposcopy and cervical pathology (ASCCP) acknowledges the risk and […]

Read More
  • BiotechToday
  • World

High risk of COVID-19 in organ transplant patients

BioTech Today July 29, 2021July 29, 2021

Soumya Shraddhya Paul, Amity University, Noida The extent to which Covid vaccinations can protect people who have organ transplants is yet unknown. Transplantation doctors have long feared that the Covid vaccinations aren’t providing enough protection to patients undergoing transplants. Few studies have suggested that even after being completely vaccinated with mRNA vaccines, which are believed […]

Read More
  • BiotechToday
  • World

Novel Strategies for Clostridioides Difficile Infection Treatment

BioTech Today July 15, 2021July 14, 2021 2

Subhajit Nan, Amity University, Kolkata Clostridioides Difficile is a bacterium responsible for causing severe diarrhea and inflammation of the colon (colitis). Though guidelines for infection control measures are firmly in place, Clostridioides Difficile Infection or CDI remains the chief cause of diarrhea associated with healthcare. Since the burden associated with CDI is high, both from […]

Read More
  • BiotechToday
  • World

Leukocytoclastic vasculitis occurrence after SARS-CoV2 vaccine

bioxone July 4, 2021July 4, 2021

Madhavi Bhatia,NIPER Guwahati SARS-covid-19 is now well-known as a severe acute respiratory syndrome that has affected all parts of the world. It has caused almost 3.9 million deaths worldwide resulting in a global pandemic. To curb the disease, various drugs are approved and used worldwide.  Today, immunization is considered a safe and effective tool to […]

Read More
  • BiotechToday
  • India

India set to begin the COVID-19 vaccination soon

bioxone November 7, 2020November 7, 2020 1

Prama Ghosh, Amity University Kolkata India is preparing to roll out COVID-19 vaccines with Anganwadi centres, schools, panchayat buildings and other such setups and buildings identified by the state governments as vaccination sites in addition to healthcare facilities. The anti-corona virus inoculation drive would be monitored by the Union health ministry’s digital platform and tracking […]

Read More
  • BiotechToday
  • India

Coronavirus | Government to map out cold storage facilities for COVID-19 vaccine delivery

bioxone October 11, 2020October 11, 2020 2

-Sagnik Nag, Amity University With the increasing cases of COVID fever, there’s still hope for upcoming vaccines within a few months. The hope came with a massive responsibility on the Government for mapping out its extensive cold storage to ensure the quick delivery of the vaccine across the country. A national expert group surveyed to […]

Read More
  • BiotechToday
  • World

ANIMAL-FREE MONOCLONAL ANTIBODY- A SUBSTITUTE FOR HYBRIDOMA TECHNOLOGY?

bioxone October 8, 2020October 7, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Hybridoma Technology is known for its’ large-scale production of identical antibodies. Recently, the European Commission’s Joint Research Centre (EC-JRC) urged the government to allow the development of animal-free antibodies for the production of vaccine development. This came after the work done by the Scientific Advisory Committee (ESAC) and claims were […]

Read More
  • BiotechToday
  • India
  • World

COVID-19 or flu? Which one to control first?

bioxone October 7, 2020October 7, 2020

Camelia Bhattacharyya, Amity University Kolkata Amidst the pandemic prevailing recently due to the SARS-CoV-2, there is something which still can’t be ignored, the flu which leads to thousands of deaths in the US and infects about 11% of the population each year according to CDC. With the arrival of the flu along with the COVID-19, […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy